HIV Testing of Syphilis and Gonorrhea Cases - Southern States
Eculizumab- recombinant, monoclonal C5 antibody approved for diseases associated with dysregulation of complement activation (Paroxysmal nocturnal hemoglobinuria, aplastic anemia) Associated with 1000-2000 x of meningococcal disease (Menactra) Several case reports of DGI Infection associated with eculizumab